Child Health Imprints is a Singapore based start-up company established in 2018. The company has raised $2.4 million in a pre-Series A funding round. The funding round was led by HealthXCapital, including investors such as Enterprise SG and other high net-worth individuals.
The company said in a statement that it will use the funds to expand its integrated neonatal intensive care unit (NICU) care services in the Asia-Pacific region, and obtaining international regulatory approvals.
Harpreet Singh, co-founder and chief executive at CHIL, said, “the firm is aiming to improve neonatal safety rates across countries where it operates. The company will also develop inroads into more advanced neonatal ecosystems to bring their best clinical practices to other markets across the world.”
Child Health Imprints is currently running 25 NICUs across hospitals in India including Apollo Hospitals in four cities, and New Delhi’s Sir Gangaram Hospital.
Child Health Imprints is engaged in the development and application of cutting edge informational and computational technologies including IoT, artificial intelligence and predictive analytics to the practice of medicine in neonatal intensive care units across the world with the objective of making early diagnosis of critical diseases and improving overall quality of healthcare which is being provided to neonates.
Company’s CHIL cloud platform also integrates laboratory results, and bedside clinical observations. It then analyses the data in medically comprehensive formats leveraging Machine Learning and Deep Learning technologies, which enhances the overall quality of healthcare provided to neonates in NICUs.
HrNxt.com Newsdesk has researchers and writers with an excellent domain knowledge about the talent ecosystem, and the business environment. The team keeps a tab on the latest happenings in the ecosystem to bring most relevant news and insights for our readers. You can connect with our newsdesk at newsdesk@hrnxt.com.